If any systemic symptoms appear, the use of this product should be discontinued.
Clinically Significant Adverse Reactions (Frequency unknown): Shock, anaphylaxis: Because shock and anaphylaxis may occur, adequate observation of patients is required. If any symptom of erythema, eruption, dyspnea, decreased blood pressure, and eyelid edema is observed, the use of this product should be discontinued, and adequate measures should be implemented.
Other Adverse Reactions: If any of the following adverse reactions is observed, appropriate measures should be taken including discontinuation of treatment. (See Table 3.)

View ADR Reporting Link